The total CR is 62.0% and disease-free survival (DFS) rate and overall survival (OS) rate at five-year are 52.3% and 46.8%,respectively.

• 全组患者治疗后的完全缓解(CR)率为62.；0%25，5年无病生存率和总生存率分别为52